1 Min Read
Aug 9 (Reuters) - Aptose Biosciences Inc
* Aptose biosciences reports financial results for the second quarter ended june 30, 2016
* Q2 loss per share c$0.46 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.